Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3849-3854

  Ishikawa, Hisatake ^a   Kikkawa, Fumitaka ^b   Tamakoshi, Koji ^b   Matsuzawa, Katsuji ^c   Kawai, Michiyasu ^d   Suganuma, Nobuhiko ^b   Tomoda, Yutaka ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ANJO KOSEI HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Carhoplatin; Cervical cancer; Cisplatin; Ncoadjuvant chemotherapy; Ovarian cancer

Indexed keywords

CISPLATIN; PLATINUM COMPLEX;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MYOMETRIUM; OVARY; OVARY CANCER; PELVIS LYMPH NODE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; MYOMETRIUM; OVARIAN NEOPLASMS; PLATINUM; TISSUE DISTRIBUTION; UTERINE CERVICAL NEOPLASMS;

EID: 0030499481     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kikkawa F, Ishikawa H, Tamakoshi K, et al: Prognostic evaluation of lymphadenectomy for epithelial ovarain cancer. J Surg Oncol 60: 227-231, 1995.
2. Morikawa Y, Kawai M, Kano T, et al: Clinical remission criteria for epithelial carcinoma of the ovary. Gynecol Oncol 48: 342-348, 1993.
3. Burghardt F, Giranli F, Lahousen M, Tamussino K, Stettner H: Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40: 103-106, 1991.
4. Marsoni S, Toni V, Valsecchi MG, et al: Prognostic factors in advanced epithelial ovarian cancer. Br J Cancer 62: 444-450, 1990.
5. Fanning J, Bennett TZ, Hilger RD: Meta-analysis of cisplatin. Doxorubicin. and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma. Obstet Gynecol 80: 954-960, 1992.
6. Fuller AF Jr. Flliott N, Kosloff C, Hoskins W, Lewis JI, Jr: Determination of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 33: 34-39, 1989.
7. Montana GS, Fowler WC, Varia MA. et al: Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 57: 148-154, 1986.
8. Scambia G, Benedetti PP, Foli E, et al. Squamous cell carcinoma antigen: prognostic significance and role in the menitoring of ncoadjuvant chemotherapy response in cervical cancer. J Clin Oncol 12: 2309-2316, 1994.
9. Jones WB: New approaches to high-risk cervical cancer. Advanced cervical cancel. Cancer 71: 1451-1459. 1003.
10. Deppe G, Malviya VK, Han I, et al. A preliminary report of combination chemotherapy with cisplatin and mitomycin-C followed by radical hysterectomy or radiation therapy in patients with locally advanced cervical cancer. Gynecol Oncol 42: 178-181, 1991.
11. Scarabelli C, Zarrelli A, Gallo A, Visentin MC: Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. Cancer 76: 1019-1026, 1995.
12. Lange RC, Spencer RP, Harder HC: The antitumor agent cisPt(NH.iliCli: distribution studies and dose calculations for 193mPt and 195mPt. J Nucl Med 14: 191-195, 1973.
13. Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM: Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSCI19875) to dogs. Cancer Res 36: 2340-2344, 1976.
14. Pera MF Jr. Harder HC: Analysis for platinum in biological material by flameless atomic absorption spectrometry. Clin Chem 23: 1245-1249, 1977.
15. Kuehnle H, Mecrpohl HG, Eiermann W, Achterrath W: Neoadjuvant therapy for cervical cancer. Seminar Oncol 19: 94-98, 1992.
16. Benedetti PP, Scambia G, Baiocchi G, el al: Neoadjuvanl chemotherapy and radical surgery in locally advanced cervical cancer 67: 372-379, 1991.
17. Kikbiwa F, Kawai K, Oguchi H, et al: Randomized study of immunotherapy with OK-4.32 in uterine cervical carcinoma. Hur J Cancer 29: 1542-1546, 1993.
18. Kim D, Moon H, Kim K, Hwang Y, Clio S, Kim S: Two-year survival: prcoperativc adjuvant chemotherapy in the treatment of cervical cancer Stages IB and II with bulky tumor. Gynccol Oncol 2: 76-80, 1999.
19. Panici PB, Scmbia G, Baiocchi G, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67: 372-379, 1991.